FDA Inspection 1062937 — Cantrell Drug Company
The FDA completed an inspection of Cantrell Drug Company on August 22, 2018 in Little Rock, AR. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- August 22, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Little Rock, AR (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 1169 | 21 CFR 211.42(a) | Buildings of Suitable Size, Construction, Location |
| 1263 | 21 CFR 211.68(b) | Computer control of master formula records |
| 3547 | 21 CFR 211.46(b) | Equipment for Environmental Control |